Term
|
Definition
Aminoglycoside Broad (mostly neg) MOA: Inhibit protein synthesis (30s) |
|
|
Term
|
Definition
Aminoglycoside Broad (mostly neg) MOA: Inhibit protein synthesis (30s) Pseudomonas DOC |
|
|
Term
|
Definition
Aminoglycoside Broad (mostly neg) MOA: Inhibit protein synthesis (30s) Significant allergic response. Comes in Neosporin ointment/sol. (with polymixin B and either bacitracin or gramicidin) CAN BE USED IN COMBO FOR ACANTHAMOEBA |
|
|
Term
|
Definition
Aminoglycoside Broad (mostly neg) MOA: Inhibit protein synthesis (30s) Only injectable into eye |
|
|
Term
|
Definition
Tetracycline Broad, +rickettsia and chlamydia MOA: Inhibit protein synthesis (30s) Also anti-inflammatory |
|
|
Term
|
Definition
Tetracycline Broad, +rickettsia and chlamydia MOA: Inhibit protein synthesis (30s) Also anti-inflammatory |
|
|
Term
|
Definition
Tetracycline Broad, +rickettsia and chlamydia MOA: Inhibit protein synthesis (30s) Also anti-inflammatory |
|
|
Term
|
Definition
Macrolide Narrow, mostly gram+ Rickettsia, H.flu, chlamydia. Resistance common MOA: Inhibit protein synthesis (50s) DOC for legionnaires. Ophthalmic versions are ointment only. |
|
|
Term
|
Definition
Macrolide Broad. gram+/- and chlamydia MOA: Inhibit protein synthesis (50s) DOC for chlamydia (1g). Comes as azasite. Possible anti-inflammatory effect. |
|
|
Term
|
Definition
Macrolide Staph/strep skin infection and sinusitis MOA: Inhibit protein synthesis (50s) |
|
|
Term
|
Definition
Other Mostly gram +, anaerobic gram - and MRSA MOA: Inhibit protein synthesis (50s) |
|
|
Term
|
Definition
Other Broad, rickettsia, chlamydia. Pseudomonas is resistant MOA: inhibit protein synthesis (50s) Good corneal penetration but harsh side effects (gray baby syndrome, bone marrow issues) ALSO causes optic neuritis (edema, hemes, optic atrophy), decreased VA, central scotomas |
|
|
Term
|
Definition
MOA: Inhibit cell wall synthesis Narrow, gram + (few gram -) |
|
|
Term
|
Definition
Penicillin Gram +, neisseria and treponema MOA: inhibit cell wall synthesis |
|
|
Term
|
Definition
Penicllin G+ MOA: inhibit cell wall synthesis Penicillinase resistant |
|
|
Term
|
Definition
Penicllin G+ MOA: inhibit cell wall synthesis Penicillinase resistant |
|
|
Term
|
Definition
Penicllin G+ MOA: inhibit cell wall synthesis Penicillinase resistant |
|
|
Term
|
Definition
Penicllin G+ MOA: inhibit cell wall synthesis Penicillinase resistant |
|
|
Term
|
Definition
Penicillin Extended spectrum (mostly g+, some g-) MOA: inhibit cell wall synthesis |
|
|
Term
|
Definition
Penicillin Extended spectrum (mostly g+, some g-) MOA: inhibit cell wall synthesis |
|
|
Term
|
Definition
Penicillin Gram+, anti-pseudomonal MOA:inhibit cell wall synthesis |
|
|
Term
|
Definition
Penicillin Gram+, anti-pseudomonal MOA:inhibit cell wall synthesis |
|
|
Term
|
Definition
Cephalosporin Gram +, neisseria MOA:inhibit cell wall synthesis 1st gen |
|
|
Term
|
Definition
Cephalosporin Gram +, neisseria MOA:inhibit cell wall synthesis 1st gen |
|
|
Term
|
Definition
Cephalosporin Gram +, neisseria MOA:inhibit cell wall synthesis 1st gen |
|
|
Term
|
Definition
Cephalosporin Gram +, neisseria MOA:inhibit cell wall synthesis 1st gen IV |
|
|
Term
|
Definition
Cephalosporin Gram +, neisseria, some g- MOA:inhibit cell wall synthesis 2nd gen |
|
|
Term
|
Definition
Cephalosporin Gram +, neisseria, some g- MOA:inhibit cell wall synthesis 2nd gen |
|
|
Term
|
Definition
Cephalosporin Gram +, neisseria, some g- MOA:inhibit cell wall synthesis 2nd gen |
|
|
Term
|
Definition
Cephalosporin More gram -, less gram +. better for MRSA than other cephalosporins MOA:inhibit cell wall synthesis 3rd gen |
|
|
Term
|
Definition
Cephalosporin More gram -, less gram +. better for MRSA than other cephalosporins MOA:inhibit cell wall synthesis 3rd gen Can be fortified |
|
|
Term
|
Definition
Mostly gram +cocci/bacilli MOA: inhibit cell wall Lots of side effects |
|
|
Term
|
Definition
MOA: disrupts bacterial membrane structure Narrow, gram- including enteric rods. 2ns choice for pseudomonas Great in combination |
|
|
Term
|
Definition
MOA: Inhibit cell membrane Gram + |
|
|
Term
|
Definition
Fluoroquinolone broad (most g+ resistant) MOA: disrupt DNA synthesis and supercoiling 2nd gen Precipitates in cornea |
|
|
Term
|
Definition
Fluoroquinolone broad (most g+ resistant) MOA: disrupt DNA synthesis and supercoiling 2nd gen |
|
|
Term
|
Definition
Fluoroquinolone broad (most g+ resistant) MOA: disrupt DNA synthesis and supercoiling 2nd gen |
|
|
Term
|
Definition
Fluoroquinolone broad (most g+ resistant) MOA: disrupt DNA synthesis and supercoiling 3rd gen Comes as 1.5% (Iquix) |
|
|
Term
|
Definition
Fluoroquinolone broad more gram + than others MOA: disrupt DNA synthesis and supercoiling.Mess with DNA gyrase and topoisomerase 4th gen Can come self-preserved |
|
|
Term
|
Definition
Fluoroquinolone broad, more gram+ than others MOA: disrupt DNA synthesis and supercoiling.Mess with DNA gyrase and topoisomerase 4th gen |
|
|
Term
|
Definition
Chloro-Fluoroquinolone broad, more gram + than others and less resistance MOA: disrupt DNA synthesis and supercoiling. Mess with DNA gyrase and topoisomerase 4th gen |
|
|
Term
|
Definition
Chemotherapeutic agent Broad, more gram+ MOA: inactivates dihydrofolate reductase |
|
|
Term
|
Definition
Chemotherapeutic agent Sulfonamide Wide spectrum. Resistance in US MOA: interrupts bacterial folic acid synthesis by competing with PABA |
|
|
Term
|
Definition
Chemotherapeutic agent Sulfonamide Wide spectrum. Resistance in US MOA: interrupts bacterial folic acid synthesis by competing with PABA |
|
|
Term
|
Definition
Antiviral Inhibits DNA synthesis Thymidine analog DOC for HSEK |
|
|
Term
|
Definition
Antiviral Inhibits DNA synthesis Gel For HSVEK. Less frequent dosing, less tocixity (targets virus) Can be used for adenovirus in theory Oral for CMV |
|
|
Term
|
Definition
Antiviral Produg activated by HSV thymidine kinase Can be used prophylactically or for acute HSK or HZO |
|
|
Term
|
Definition
Antiviral Prodrug of acyclovir Better bioavailability Can be used for prophylaxis |
|
|
Term
|
Definition
ANtiviral Inhibits viral DNA For genital and ophthalmic HSV Pro-drug of penciclovir |
|
|
Term
|
Definition
Antifungal (topical) Broad spectrum (candida, aspergillus etc) Only FDA approved treatment |
|
|
Term
|
Definition
Anti-fungal Can be formulated into topical, but usually systemic Toxic |
|
|
Term
|
Definition
Treatment of acanthamoeba |
|
|
Term
Polyhexamethylene biguanide |
|
Definition
Treatment of acanthamoeba |
|
|
Term
|
Definition
Kills everything Very toxic to eye Pre-surgical or for adenovirus (EKC) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Ester-steroid Less IOP increase, less cataracts etc. Comes in drop (0.5%),preservative free ointment,and now gel (few shakes) Comes in 0.2% for allergies (alrex) |
|
|
Term
|
Definition
Ketone Steroid Acetate, alcohol, phosphate (strongest to weakest) Potent Comes as an oral (for mild to severe inflammation) |
|
|
Term
|
Definition
Ketone steroid Acetate=Flarex, alcohol=FML, phosphate (strongest to weakest) |
|
|
Term
|
Definition
Ketone steroid Acetate, alcohol, phosphate (strongest to weakest) Strongest steroid response! |
|
|
Term
|
Definition
Prednisolone derivate with better potency, lipophilicity, and better anti-inflammatory affect. NO SHAKE (emulsion). |
|
|
Term
|
Definition
Ketone soft steroid Inactivated metabolite of pred Strong but poor penetrance (so weak action) |
|
|
Term
|
Definition
Injectable steroid (usually periocular) |
|
|
Term
|
Definition
Injectable steroid Used for chalazia and post-seg stuff Comes as an implant for diabetic macular edema Available orally for moderate inflammation |
|
|
Term
|
Definition
Dexamethazone implant for macular edema following vein occlusions |
|
|
Term
|
Definition
Fluocinolone acetonide implant (operating room) for chronic uveitis |
|
|
Term
|
Definition
Fluocinolone acetonide implant (in office) for Diabetic ME |
|
|
Term
|
Definition
Ganciclovir implant for CMV retinitis |
|
|
Term
|
Definition
Tobramycin and loteprednol Potent steroid/antibiotic Good for s. aureus. |
|
|
Term
|
Definition
Gentamicin and pred acetate Potent steroid/antibiotic |
|
|
Term
|
Definition
Tobramycin and dexamethasone Potent steroid/antibiotic comes in ST form which has less IOP affects and is a suspension with xanthan gum (longer retention) |
|
|
Term
|
Definition
neomycin, polymyxin B, and pred acetate Potent sensitizing antibiotic and strong steroid. |
|
|
Term
|
Definition
neomycin, polymyxin B and dexamethasone potent sensitizing antibiotic and weak steroid |
|
|
Term
|
Definition
Neomycin polymyxin b and hydrocortisone Potent sensitizing antibiotic and VERY weak steroid |
|
|
Term
|
Definition
Mast cell stabalizer 1st gen |
|
|
Term
|
Definition
Mast cell stabalizer 1st gen |
|
|
Term
|
Definition
Mast cell stabalizer 2nd gen |
|
|
Term
|
Definition
Mast cell stabalizer 2nd gen |
|
|
Term
|
Definition
Dual action allergy med Either pataday (0.2%) or patanol (0.1%) |
|
|
Term
|
Definition
|
|
Term
|
Definition
Dual action allergy med Comes as Zaditor, Alaway, Refrsh Eye Itch Relief, Claritin and Zyrtec EYE |
|
|
Term
|
Definition
|
|
Term
|
Definition
Rx dual action allergy med |
|
|
Term
|
Definition
Rx dual action allergy med |
|
|
Term
|
Definition
Nasal allergy spray that works for eye allergies. |
|
|
Term
|
Definition
Classical topical NSAID Peripheral acting analgesic Can be used for allergy relief (also available PF and in LS form for less sting) |
|
|
Term
|
Definition
Mildly sedating oral antihistimine 1st gen |
|
|
Term
|
Definition
Mildly sedating oral antihistimine 1st gen |
|
|
Term
|
Definition
Minimally sedating oral antihistamine 2nd gen |
|
|
Term
|
Definition
Minimally sedating oral antihistamine 2nd gen |
|
|
Term
|
Definition
Minimally sedating oral antihistamine 2nd gen |
|
|
Term
|
Definition
Minimally sedating oral antihistamine 2nd gen |
|
|
Term
|
Definition
Minimally sedating oral antihistamine 2nd gen |
|
|
Term
|
Definition
Mildly sedating oral antihistamine Benedryl |
|
|
Term
|
Definition
|
|
Term
|
Definition
Antihistimine/vasoconstrictor |
|
|
Term
|
Definition
Antihistimine/vasoconstrictor |
|
|
Term
|
Definition
Antihistimine/vasoconstrictor |
|
|
Term
|
Definition
Immunosuppressive agent Good for dry eye and off label for allergies |
|
|
Term
|
Definition
|
|
Term
|
Definition
Anesthetic and mydriatic Blocks NE reuptake (indirect adrenergic) Causes mydriasis and vasoconstriction Used to diagnose horners |
|
|
Term
|
Definition
Anesthetic More sting than benoxinate or proparacaine Contraindicated with sulfonamides Comes in viscous sol. |
|
|
Term
|
Definition
Anesthetic Only available with NaFl For tono |
|
|
Term
|
Definition
Anesthetic Popular in optometry Available with NaFl. Less sting |
|
|
Term
|
Definition
Preservative free amide anesthetic (if akten) Also comes in a patch and as an injectable. |
|
|
Term
|
Definition
Cream anesthetic. Good for post herpetic neuralgia |
|
|
Term
|
Definition
Often combined with anesthetic to decrease bleeds and systemic absorbtion. |
|
|
Term
|
Definition
Mydriatic Direct acting adrenergic Good vasoconstrictor, can be used for horner's and ptosis. 10% problematic with heart issues and have drug interactions. |
|
|
Term
|
Definition
Mydriatic Indirect acting adrenergic Increases NE release from nerve terminal Also inhibits NE reuptake Can cause vasoconstriction. Few systemic side effects topically. May also be used in horner's. Available in paramyd (combo with tropicamide) |
|
|
Term
|
Definition
Reverses dilation from phenyl or hydroxyamphetamine. Causes redness and ptosis |
|
|
Term
|
Definition
Cyclopegic Works 7-12 days For uveitis, accomodative esotropes or to break synechiae. Has overdose risk (hot as a hare, mad as a hatter, dry as a bone, red as a beet). 20 drops of 1% fatal to children |
|
|
Term
|
Definition
Cycloplegic Works 5-7 days May be better for people with dark irides For uveities, synechiae or an alternate to atropine. MORE toxicity risk (central). Available as a motion sickness patch |
|
|
Term
|
Definition
Cycloplegic Works 1-3 days DOC for uveitis and atropine-sensitivity. Long dilation time and poor cycloplegic potency |
|
|
Term
|
Definition
Cycloplegic Works 24 hours DOC for cycloplegic refraction. Comes in a spray. Less SE in 1% |
|
|
Term
|
Definition
Cycloplegic Works 4-6 hours Poor effect in a red eye. Used in combination (with anesthetic increases effect). DM patients resistent without phenyl. Less impacted by iris pigmentation, increased concentration doesn't increase dilation. Mostly for dilation! Safe with heart probs |
|
|
Term
|
Definition
Classic topical NSAID Peripheral acting analgesic Acetic acid non-salicylate Generics can cause corneal melt in sick eyes |
|
|
Term
|
Definition
New topical opthalmic NSAID (better anti-inflammatory) Peripheral acting analgesic |
|
|
Term
|
Definition
New topical opthalmic NSAID (better anti-inflammatory) Peripheral acting analgesic |
|
|
Term
|
Definition
Oral NSAID Cox-2 inhibitor Peripheral acting analgesic Ceiling effect May increase risk of heart attack/stroke |
|
|
Term
|
Definition
Oral non-salicylate NSAID Propionic acid Peripheral acting analgesic Ceiling effect More effective than aspirin |
|
|
Term
|
Definition
Oral non-salicylate NSAID Propionic acid Peripheral acting analgesic 50 mg q4g equal to tylenol with codeine. Good for ocular pain |
|
|
Term
|
Definition
Oral non-salicylate NSAID Propionic acid Peripheral acting analgesic May be safer because mostly cox-2 |
|
|
Term
|
Definition
Oral non-salicylate NSAID Acetic acid Peripheral acting analgesic Causes corneal deposits (stromal specks and whorl-k) and retinal pigment scattering/depigmentation |
|
|
Term
|
Definition
Oral NSAID Peripheral acting analgesic Pyrrolo-pyrrole Strongest. Only post surgical |
|
|
Term
|
Definition
Oral NSAID Peripheral acting analgesic Anthranilic acid |
|
|
Term
|
Definition
Oral NSAID Peripheral acting analgesic Fenolic acid 57 hr half life |
|
|
Term
|
Definition
Narcotic (central acting) Modest analgesic, moderate sedative Often combined with NSAIS and aspirin |
|
|
Term
Acetaminophen (tylenol/APAP) |
|
Definition
Non-narcotic analgesic Maybe central acting Analgesic and antipyretic Toxicity possible and causes liver,kidney and heart probs |
|
|
Term
|
Definition
Narcotic (central acting) Modest analgesic, mild sedative Comes in combos with acetaminophen aspirin and ibuprofen (vicoden, lortab, vicoprofen) |
|
|
Term
|
Definition
Central acting analgesic Non-scheduled med . Lower risk of abuse, interact with MAOI |
|
|
Term
|
Definition
Anti-convulsant Changes the way the body senses pain Good for post-herpetic neuralgia |
|
|
Term
|
Definition
Adjuvant No direct analgesic affect but increases effect of NSAID/narcotics |
|
|
Term
|
Definition
Analgesic Anti-inflammatory Peripheral acting analgesic Anti-pyretic and anti-platelet activity Causes Reye's in sick kids |
|
|
Term
Doan's pills (magnesium salicylate) |
|
Definition
Non-narcotic analgesic Less platelet activity, anti-inflammatory and GI issues than aspirin |
|
|
Term
|
Definition
Anti-malarial Treats malaria and autoimmune disorders Causes whorl K (verticillata), glare/halos bullseye maculopathy |
|
|
Term
|
Definition
Anti-psychotic Causes anterior subcapsular stellate cataracts (dense 3-9 point stars), fuzzy vision, halos |
|
|
Term
|
Definition
Cause chrysiasis (gold deposits in cornea and lens) Look similar to agryosis (from silver), chalcosis (copper), siderosis (iron) and bismuthiasis (bismuth) |
|
|
Term
|
Definition
Used to treat psoriasis/vitiligo Are photosensitizing and cause cataracts |
|
|
Term
|
Definition
Used to treat cardiac arrhythmia Causes whorl-k (superficial, brownish similar to hudson stali line) also cause lens deposits, decrease VA |
|
|
Term
|
Definition
Causes decreased corneal sensation, ulceration, injection, and vision loss. May have associated infection. |
|
|
Term
|
Definition
May be used for many things including JRA Cause PSC |
|
|
Term
|
Definition
Used for prostate issues Cause floppy iris syndrome |
|
|
Term
|
Definition
Acne med Causes corneal opacities, neo, SPK, bleph, dry eye/CL intolerance, pseudotumor cerebri, birth defects, impaired dark adaptation |
|
|
Term
|
Definition
Used to treat TB Causes retrobulbar optic neuritis (decreased VA, color vision probs, VF loss) |
|
|
Term
|
Definition
Used for congestive heart failure Cause snowy vision, color vision issues and entopic phenomena |
|
|
Term
|
Definition
Anti-cancer drug Cause yellow/white refractile bodies in macular and edema, decreased VA, VF defect |
|
|
Term
|
Definition
Cause retinal emboli (tiny, yellow/white spots resulting in occlusions and neo) |
|
|
Term
|
Definition
Not used much anymore Causes CME, maybe decreased VA |
|
|
Term
|
Definition
For sexual arousal Causes vasodilation. mayb be related to NAION |
|
|
Term
|
Definition
Prostaglandin analogue Increase uveoscleral outflow Less redness |
|
|
Term
|
Definition
Prostaglandin analogue Increase uveoscleral outflow Better for african americans Maintains effects for 44 hours. BAK free |
|
|
Term
|
Definition
Prostaglandin analogue Increase uveoscleral outflow |
|
|
Term
|
Definition
Amide-based prostaglandin analogue (prostanoid) Increase uveoscleral outflow, (+/- outflow facility) Stings more Also available as latisse for eyelash growth |
|
|
Term
Timolol maleate (timoptic) |
|
Definition
Beta blocker Decrease aqueous production Gold standard Available PF (ocudose) and in gel. Istalol formulation is more lipophilic |
|
|
Term
|
Definition
Beta blocker Decrease aqueous production Cheaper than timoptic but brand name |
|
|
Term
|
Definition
Beta blocker Decrease aqueous production Less effective but has intrinsic sympathomimetic activity ( less SE on depression/cholesterol) |
|
|
Term
|
Definition
Beta blocker Decrease aqueous production Beta 1 selective with calcium channel blocking effect/less vasoconstriction Less IOP drop but maintains VF better |
|
|
Term
|
Definition
Beta blocker decrease aqueous production longest half life |
|
|
Term
|
Definition
Epinephrine prodrug Acts as sympathomimetic Decrease aqueous production Allergy risk |
|
|
Term
|
Definition
Alpha 2 agonist Decrease aqueous production Not effective as a third med with B-blocker and CAI For ACG and to prevent IOP spike during surgery Allergy probs Tachyphylaxis |
|
|
Term
|
Definition
Alpha 2 agonist Decrease aqueous production and increase uveoscleral outflow (dual action) Can cause lid redness and miosis in dim light. Available with b-blockers (combigan) and CAI (simbrinza) in combo. |
|
|
Term
|
Definition
CAI Decrease aqueous production Cannot add to latanoprost or oral CAI. Available in combo with timolol (cosopt) |
|
|
Term
|
Definition
CAI Decrease aqueous production Less SE Available in combo with brimonidine (sabrinza) |
|
|
Term
|
Definition
Oral CAI Decrease aqueous production More for angle closure, macular edema or as a diuretic |
|
|
Term
|
Definition
Oral CAI Decrease aqueous production less SE than diamox but still many and multiple contraindications (class wide) |
|
|
Term
|
Definition
Hyperosmotic Decrease IOP by osmosis In emergency situations Warn diabetics of glucose load Causing vomiting! among other SE of dehydration |
|
|
Term
|
Definition
Hyperosmotic Decrease IOP by osmosis Safe for diabetics, IV only |
|
|
Term
|
Definition
Hyperosmotic Decrease IOP by osmosis Not safe for diabetics IV only |
|
|
Term
|
Definition
Miotic direct acting Parasympathomimetic Increase aqueous outflow Better in light irides Available in gel or sol. Ok for angle closure. For non-presbyopes SE are significant. SLUD is SE in all people (rare) DOC for Pigment dispersion glaucoma Available as an insert (ocusert) which operates under zero order kinetics. Also comes with timolol as combo (rare) |
|
|
Term
|
Definition
Miotic Direct acting Parasympathomimetic Increase aqueous outflow Poor penetration, more SE. Surgery only |
|
|
Term
|
Definition
Miotic Indirect acting long term late stage POAG and accomodative ET |
|
|
Term
|
Definition
Miotic Indirect acting long term late stage POAG and accomodative ET and as an atropine poisoning reversal |
|
|